Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon

•The level of TGF-β could be used as an early indicator for functional cure but not for HBeAg seroconversion. The relationship between the serum transforming growth factor (TGF)-β level and HBsAg loss has not been clearly elaborated in patients with chronic hepatitis B (CHB). Two cohorts of patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Virus research 2022-02, Vol.309, p.198657-198657, Article 198657
Hauptverfasser:	Wu, Li-Li, Li, Xiao-Yan, Deng, Hong, Xie, Dong-Ying, Gu, Yu-Rong, Bi, Yan-Hua, Huang, Yue-Hua, Gao, Zhi-Liang
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use chronic hepatitis B DNA, Viral functional cure HBsAg loss Hepatitis B e Antigens Hepatitis B Surface Antigens Hepatitis B virus - genetics Hepatitis B, Chronic Humans Interferon-alpha - therapeutic use Polyethylene Glycols - therapeutic use Recombinant Proteins - therapeutic use TGF-β Transforming Growth Factor beta Transforming Growth Factors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!